These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18713977)

  • 21. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
    Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective Priming of Herpes Simplex Virus-Specific CD8
    Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.
    Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C
    Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Nov; 177(9):6018-24. PubMed ID: 17056526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
    Keller SA; Bauer M; Manolova V; Muntwiler S; Saudan P; Bachmann MF
    J Immunol; 2010 Jan; 184(1):26-9. PubMed ID: 19949081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.
    Furuta K; Ishido S; Roche PA
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.
    Uhl M; Kepp O; Jusforgues-Saklani H; Vicencio JM; Kroemer G; Albert ML
    Cell Death Differ; 2009 Jul; 16(7):991-1005. PubMed ID: 19229247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
    Tagliani E; Guermonprez P; Sepúlveda J; López-Bravo M; Ardavín C; Amigorena S; Benvenuti F; Burrone OR
    J Immunol; 2008 Mar; 180(5):3201-9. PubMed ID: 18292544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
    Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
    J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.
    Smith CM; Wilson NS; Waithman J; Villadangos JA; Carbone FR; Heath WR; Belz GT
    Nat Immunol; 2004 Nov; 5(11):1143-8. PubMed ID: 15475958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.